Insulin Resistance & Stubborn Weight

Insulin resistance occurs when your cells stop responding efficiently to insulin, the hormone responsible for moving glucose from your bloodstream into your cells for energy. When cells become resistant, your pancreas compensates by producing more insulin. Chronically elevated insulin levels signal your body to store fat, particularly around the midsection, and make it extraordinarily difficult to lose weight through calorie restriction alone.

This condition affects an estimated 40% of adults between 18 and 44 and is a precursor to type 2 diabetes, cardiovascular disease, and metabolic syndrome. Many people with insulin resistance have no idea they have it. They experience stubborn belly fat, intense carbohydrate cravings, energy crashes after meals, and frustration with diets that work for everyone else but not for them.

The good news is that insulin resistance is not a permanent state. It is a metabolic dysfunction that responds to the right interventions. While lifestyle changes like reduced sugar intake and increased physical activity help, they are often insufficient on their own. Medical therapies that directly improve insulin signaling and reduce circulating insulin levels can break the cycle and restore your body's ability to burn stored fat.

INA's approach to insulin resistance centers on GLP-1 receptor agonist therapy, the most significant advancement in metabolic medicine in the last decade. GLP-1 medications like semaglutide and tirzepatide work by mimicking a natural gut hormone that regulates blood sugar, slows gastric emptying, and reduces appetite. Crucially, they also improve insulin sensitivity at the cellular level, addressing the root dysfunction rather than masking symptoms.

Every patient begins with a comprehensive medical intake reviewed by a board-certified physician. Based on your metabolic history, BMI, and health goals, your provider will prescribe a GLP-1 protocol tailored to your physiology, with dose adjustments over time to minimize side effects while maximizing metabolic improvement. Ongoing monitoring ensures your treatment evolves as your body responds.